Human Neuronal Cells: Possibilities in Drug Safety Testing and Beyond Human derived induced pluripotent stem cells (hiPSCs) have revolutionised research and are increasingly used for toxicology screening and disease modelling. Early detection of neurotoxicity induced by potential new therapies is a major challenge, and hiPSC-neuronal cells may provide a [...]
The Reductionist Approach The hERG assay has been a mainstay of safety screening in drug discovery for the last 2 decades. Aided by the development of high throughput automated technology, this important assay has brought unparalleled progress in our ability to design safer drugs without those properties that may [...]
ApconiX Upgrade to a QPatch ll 48 Automated Patch Clamp to Meet Demand ApconiX, the integrated toxicology and ion channel company, has acquired a QPatch ll 48 with temperature control to meet the increasing demand from their clients. As the first CRO to invest in QPatch II in the [...]
Dr Michael Morton is Attending the 31st Symposium on Medicinal Chemistry in Eastern England Dr Michael Morton is attending the 31st symposium on Medicinal Chemistry in Eastern England on Thursday 26th of November. ApconiX is also exhibiting at the virtual event. Mike commented, “RSC events are always a great [...]
The Evolving Role of Ion Channels in Shaping Successful Drug Discovery - Live Webinar For more information, or to register for this event, visit The Evolving Role of Ion Channels in Shaping Successful Drug Discovery. Join Dr Michael Morton, Director and Co-founder of ApconiX in a live webinar on [...]
Dr Laurence Bishop Attends Bio-Europe Digital 2020 Dr Laurence Bishop is attending Bio-Europe Digital 2020 from the 26th to the 29th of October. Dr Michael Morton and Dr Richard Knight joined the UK delegation at The UK Pavilion at BIO-Europe last year. ApconiX benefited from a Tradeshow Access Programme [...]
Dr Michael Morton is Attending Safety Pharmacology Society Dr Michael Morton will be attending the annual Safety Pharmacology Society Meeting being held virtually this year between 14th and 17th of September. Mike will be presenting Poster 030: Electrophysiological analysis of Seroquel’s activity in sodium ion channels, CiPA ion channels [...]
ApconiX Welcomes Dr Laurence Bishop ApconiX is delighted to welcome Dr Laurence Bishop to the team as our Head of Business Development. Laurence is an experienced DMPK and toxicological scientist with 20 years’ experience of nonclinical drug development. Specialising in business development for the past 13 years, we are [...]
ApconiX Welcomes Dr Selvan Bavan ApconiX welcomes Dr Selvan Bavan, who joins us to carry out ion channel research using manual patch-clamp while learning more about using automated patch-clamp by working with Dr Michael Morton and Dr Karen Jones. Selvan commented, “Conventional manual patch-clamp is regarded as a ‘gold [...]
ApconiX Welcomes Charlotte North ApconiX welcomes Charlotte North to the team. Charlotte graduated from Sheffield University in July with a degree in Biomedical Sciences and is working in the ApconiX Ion Channel Laboratory as an industry placement student this month. Charlotte has been spending her time, since graduating, exploring [...]
